By Dr. Shantling Nigudgi, Sr Consultant, Radiation Oncology, HCG Cancer Hospital, Kalaburagi.
When prolonged flu seasons began stretching into weeks across India, many people learned to live with a sore throat the way they live with bad traffic. Trying to fix a hoarse voice with warm water or a salt water gargle became habit, blaming pollution or the stubborn cold as the cause. A lump in the neck, noticed one morning in the mirror, was attributed to a swollen gland and dismissed as probably nothing. For the specialist who examines it, however, it may be something else entirely.
Head and neck cancers malignancies of the oral cavity, throat (pharynx), voice box (larynx), salivary glands, and nasal passages account for nearly 30% of all cancers diagnosed in India, according to the National Cancer Registry Programme (NCRP). What is more worrying is that the majority of patients arrive at specialist centres only at Stage III or IV, when treatment is longer, more complex, and the odds considerably less favorable.
The reason for that delay is rooted in how these cancers behave in their early stages, which is to say, almost invisibly.
A Condition That Hides in Plain Sight
Head and neck cancers borrow the language of everyday ailments. A tiny, painless white patch, known medically as leukoplakia, on the inner cheek is easily mistaken for a minor burn from a hot meal. A velvety red spot (erythroplakia) on the gum is dismissed as a canker sore. A hoarse voice after two weeks of smog is chalked up to worsening air quality indices rather than investigated. Even a lump in the neck, which may signal an enlarged lymph node responding to an underlying tumor in the pharynx or thyroid, can feel deceptively routine and nothing more. Pain is often absent in early-stage head and neck cancer, which is precisely why patients, and sometimes even primary care physicians, delay onward referral.
Seven Signs and Three Weeks to Act on It
Each of the following symptoms demands medical assessment if it persists beyond three weeks.
A lump or swelling in the neck, jaw, or mouth: A painless, persistent lump is one of the most common early presentations of head and neck cancer, often representing an enlarged lymph node responding to a nearby tumor.
A sore throat that will not resolve: A sore throat that lingers beyond three weeks without fever or accompanying cold symptoms should be assessed by a specialist.
Hoarseness or a change in voice: A voice that has changed quality or become persistently hoarse, without an obvious trigger such as vocal strain or a recent infection, can be an early indicator of laryngeal cancer.
Difficulty swallowing: Whether it is pain on swallowing (odynophagia) or a sensation of food catching in the throat (dysphagia), this symptom should not be attributed to ageing or acidity without investigation.
A non-healing mouth ulcer or unusual patches: Any ulcer that has not healed within three weeks, or white (leukoplakia) and red (erythroplakia) patches on the tongue, gums, or inner cheeks, must be assessed and, if necessary, biopsied.
Persistent one-sided earache: Unilateral earache without signs of ear infection can be referred pain originating from a tumor in the throat or pharynx.
Unexplained weight loss: Significant, unintentional weight loss alongside any of the above symptoms is a systemic red flag requiring urgent clinical workup.
India Has a Distinct Risk Profile
India’s head and neck cancer burden cannot be understood through the lens of cigarettes and whisky alone. In states like Bihar, Uttar Pradesh, and Odisha, tobacco products like khaini, gutka, and betel quid are rituals that cut across income levels and age groups. The carcinogens in these products act directly on the oral mucosa, which is why squamous cell carcinoma of the buccal cheek is among the most common presentations in Indian cancer centers. Oncologists are now routinely seeing patients in their thirties and forties with advanced oral cancers, an age profile that would have been unusual two decades ago. The Human Papillomavirus (HPV-16) is an additional and growing risk factor, now increasingly documented among younger, non-smoking urban populations.
The Tools That Detect Cancer Early
High-resolution endoscopy with narrow-band imaging (NBI) allows clinicians to identify subtle mucosal changes invisible to the naked eye. Positron Emission Tomography – Computed Tomography (PET-CT) enables precise staging, while transoral robotic surgery (TORS) offers minimally invasive access to the oropharynx that was not possible a generation ago. Clinicians in Kerala and Karnataka are increasingly deploying Oral Scan, a handheld multispectral imaging device that visualizes tissue beneath the surface, identifying potentially malignant changes that a standard examination under torchlight would not detect.
Timely Consultation, the Most Effective Diagnostic Tool
Stage I and Stage II disease can often be managed through surgery, radiation, or a targeted combination of both. By Stage IV, treatment shifts increasingly toward control rather than cure, and the interventions required are more extensive, more prolonged, and harder on the patient.
Timely consultation, however inconvenient or however convinced you are that it is nothing, remains the most effective diagnostic tool in circulation. The technologies exist to detect these cancers early. The harder problem has always been getting people through the door in time to use them.